State Street’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.98M Buy
1,011,189
+34,416
+4% +$80.7K ﹤0.01% 3305
2025
Q4
$2.65M Sell
976,773
-479,955
-33% -$1.58M ﹤0.01% 3245
2025
Q3
$6.16M Sell
1,456,728
-14,441
-1% -$63.5K ﹤0.01% 2908
2025
Q2
$7.33M Sell
1,471,169
-296,741
-17% -$1.29M ﹤0.01% 2771
2025
Q1
$7.8M Buy
1,767,910
+97,408
+6% +$457K ﹤0.01% 2681
2024
Q4
$7.77M Buy
1,670,502
+821,032
+97% +$4.51M ﹤0.01% 2759
2024
Q3
$5.9M Sell
849,470
-262,022
-24% -$2.06M ﹤0.01% 2885
2024
Q2
$8.67M Buy
1,111,492
+302,936
+37% +$2.24M ﹤0.01% 2636
2024
Q1
$5.74M Buy
808,556
+30,671
+4% +$203K ﹤0.01% 2868
2023
Q4
$5.21M Sell
777,885
-148,442
-16% -$836K ﹤0.01% 2924
2023
Q3
$5.22M Buy
926,327
+78,698
+9% +$525K ﹤0.01% 2895
2023
Q2
$4.68M Buy
847,629
+63,088
+8% +$340K ﹤0.01% 3024
2023
Q1
$4.9M Buy
784,541
+10,884
+1% +$60.7K ﹤0.01% 2999
2022
Q4
$3.61M Buy
773,657
+270,280
+54% +$1.33M ﹤0.01% 3179
2022
Q3
$2.35M Sell
503,377
-39,131
-7% -$247K ﹤0.01% 3369
2022
Q2
$3.21M Buy
542,508
+179,339
+49% +$2M ﹤0.01% 3313
2022
Q1
$7.02M Buy
363,169
+58,532
+19% +$1.34M ﹤0.01% 3017
2021
Q4
$9.96M Buy
304,637
+16,438
+6% +$661K ﹤0.01% 2913
2021
Q3
$11.8M Buy
288,199
+10,965
+4% +$398K ﹤0.01% 2788
2021
Q2
$9.98M Buy
277,234
+167,742
+153% +$6.19M ﹤0.01% 2921
2021
Q1
$4.27M Sell
109,492
-9,470
-8% -$426K ﹤0.01% 3115
2020
Q4
$4.8M Buy
+118,962
New +$5.47M ﹤0.01% 2981

Other funds holding GDRX

State Street's GDRX Position: Q1 2026 in Review

State Street increased its GoodRx Holdings (GDRX) stake by 3.5% in Q1 2026, buying an estimated $80.7K and bringing the position to 1,011,189 shares worth $1.98M. The position accounts for ﹤0.01% of the portfolio, ranked #3305.

State Street first reported a position in GDRX in Q4 2020 and has held it in 22 quarters since. The position peaked at $11.8M in Q3 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • State Street held 1,011,189 shares of GoodRx Holdings worth $1.98M as of Q1 2026.
  • State Street bought 34,416 GoodRx Holdings shares in Q1 2026, an estimated $80.7K.
  • GoodRx Holdings made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3305 holding.
  • State Street first reported a position in GoodRx Holdings in Q4 2020 and has held it in 22 quarters since.
  • State Street's GoodRx Holdings position peaked at $11.8M in Q3 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.